Skip to main content

bio logoThe BIO CEO & Investor Conference is presented by BIO, the non-profit policy and advocacy organization for the biotechnology industry. BIO is the convener of the industry's largest biotechnology gathering in the world, the BIO International Convention

For more than 25 years, BIO has served as the biotech industry’s leading voice advocating to the U.S. government how good policies help and bad policies hinder biomedical innovations reaching patients.  As a new presidential administration and U.S. Congress start their work, BIO will use this conference to share our latest news on policy developments to navigate as well as seek your input on issues BIO should prioritize.

group of people meeting

What is the BIO CEO & Investor Conference?

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded, late-stage private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

Each year the BIO CEO & Investor Conference provides a forum where institutional investors, industry analysts, and senior biotechnology executives have the opportunity to shape the future investment landscape of the biotechnology industry, financing promising discoveries to results in better patient outcomes.

Register

Event Features

Partnering

Partnering

Make the right connections during meetings scheduled in the BIO One-on-One Partnering™ system, the most efficient way to do business in the biotech and pharma industry.

Sessions    

Sessions    

Gain insights during issue oriented plenary sessions and discussions focused on hot therapeutic areas and key business issues.

Company Presentations

Company Presentations

Find out about the latest innovations in biotech from senior-level company execs presenting their company’s pipeline, R&D activities, business objectives and investment goals. 
Networking

Networking

Meet new partners and reinforce your industry relationships during networking events immediately following the days' programs.

Who attends the event?

C-Level Biotech / Biopharma Executives

43% of attendees work in biopharma

75% of attendees are CEO / C-Suite

Institutional Investors, VCs and Private Equity Investors

42% of attendees are investors
Testimonials

Conference Sponsors


 

Sign up for updates

Stay up-to-date on the BIO CEO and Investor Conference via email.

SIGN UP